HIGH

STAQ Pharma Ketamine Hydrochloride Injection 50 mL Recall for Labeling Errors (2025)

STAQ Pharma recalled Ketamine Hydrochloride injections distributed nationwide in the United States. The labeling has incorrect or missing lot and expiration date information. Stop using the product and contact STAQ Pharma or your healthcare provider for guidance.

Quick Facts at a Glance

Recall Date
October 9, 2025
Hazard Level
HIGH
Brand
STAQ Pharma
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Labeling: Incorrect or Missing Lot and/or Exp Date

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact STAQ Pharma, Inc. or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Ketamine Hydrochloride injection is used in clinical settings as an anesthetic or analgesic adjunct. The product is supplied in a 50 mL syringe with labeled strength of 50 mg per 5 mL.

Why This Is Dangerous

The defect is labeling. Incorrect or missing lot and expiration date information can hinder traceability and dosing accuracy, potentially affecting patient safety.

Industry Context

This recall is not described as part of a broader industry pattern in the notice.

Real-World Impact

Healthcare providers must verify labeling before use. The recall can create administrative burden and potential delays in patient care while traces are completed.

Practical Guidance

How to identify if yours is affected

  1. Check NDC 73177-0156-02 on the packaging.
  2. Check Lot number for 25156673A.
  3. Check Expiry date for 02FEB2026.

Where to find product info

FDA enforcement page link and STAQ Pharma recall communications. Manufacturer address: 14135 E 42nd Ave, Denver, CO.

What timeline to expect

No specific timeline provided for resolution or refunds. Follow STAQ Pharma guidance.

If the manufacturer is unresponsive

  • Document all attempts to contact STAQ Pharma.
  • File a complaint with FDA MedWatch if necessary.
  • Consult state pharmacy board for guidance.

How to prevent similar issues

  • Implement a labeling verification step for all drug lots before distribution.
  • Cross-check lot and expiry against the product at point of care.
  • Train staff to escalate labeling discrepancies immediately.

Documentation advice

Keep a copy of the recall notice, record lot 25156673A and expiry 02FEB2026, and save all correspondence with the manufacturer.

Product Details

Ketamine Hydrochloride, 50 mg/5 mL (10 mg/mL), in a 50 mL syringe. Brand STAQ Pharma Inc. NDC 73177-0156-02. Lot 25156673A. Expiry 02FEB2026. Distributed nationwide in the U.S.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • NDC 73177-0156-02
  • Lot 25156673A
  • Expiry 02FEB2026
  • 50 mL syringe
  • 50 mg/5 mL (10 mg/mL)
  • Recall date 2025-10-09

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
4/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
25156673A
Affected States
ALL
Report Date
October 22, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more